[ad_1]
after the study launched by the Ministry of Health, licensed in Turkey, with different forms of packaging "valsartan" It was determined that the product containing 33 active ingredients are supplied from China [19659002] According to AAA news. it was decided that the sale of 33 products would be avoided at the Drug Tracking System. The European Medicines Agency (EMA) 5 on its warning in July, the pharmaceutical Turkey and Medical Device Authority 'valsartan' active substance investigation has been launched on drugs.
According to information from the Ministry of Health Officials, these are the result of the review started on the basis of carcinogens may contain, Turkey & # 39;
In the scientific committee, the situation of drugs was discussed and in order to quickly take the necessary precautions, it was necessary to use blood pressure "valsartan" made in China and it was decided to prevent the sale of drugs for heart disease in the Drug Tracking System.
Officials say the market has active ingredients "valsartan", equivalent products that do not involve risk, and that citizens will suffer from a lack of access.
Source link
